{"id":"W2612006186","doi":"10.2147/ott.s104177","title":"New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Afatinib; Medicine; Nivolumab; Lung cancer; Pembrolizumab; Ramucirumab; Oncology; Docetaxel; Context (archaeology); Squamous-cell carcinoma of the lung; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Immunotherapy; Epidermal growth factor receptor; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004824541,0.0005654182,0.001133967,0.001922573,0.0002696979,0.0008626867,0.0007069427,0.0008109137,0.003721652],"category_scores_gemma":[0.0006189257,0.0002116786,0.0006443058,0.001732941,0.0003982338,0.00128246,0.0006572526,0.002268564,0.00169228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005083324,"about_ca_system_score_gemma":0.0008654523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006787805,"about_ca_topic_score_gemma":0.001771579,"domain_scores_codex":[0.9997974,0.00003644845,0.00003672269,0.00003652942,0.00007194719,0.00002092865],"domain_scores_gemma":[0.9997397,0.0001394766,0.00003637728,0.00000759057,0.00005467473,0.00002218348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007266154,0.00006196529,0.0001057414,0.01303216,0.00009814038,0.0001476611,0.00004982281,0.000343507,0.001177276,0.003734532,0.01926934,0.9619072],"study_design_scores_gemma":[0.00003071696,0.000106484,0.000413509,0.002844861,0.0001132012,0.0009351326,0.00004008452,0.00008813084,0.0003783141,0.00178831,0.993248,0.00001314612],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001052584,0.9984175,0.00009014676,0.0003093597,0.0001654081,0.000003707501,0.0000172135,0.000006520577,0.0008849242],"genre_scores_gemma":[0.0007831148,0.9982797,0.0001361384,0.0002369145,0.0001273633,0.000004288854,0.00002827067,0.000001621024,0.0004027043],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003721652,"threshold_uncertainty_score":0.01245016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05241281530813648,"score_gpt":0.4199899764586437,"score_spread":0.3675771611505073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}